OUTLOOK THERAPEUTICS, INC. Foreign Income Tax Expense (Benefit), Continuing Operations
OUTLOOK THERAPEUTICS, INC. (OTLK) reported Foreign Income Tax Expense (Benefit), Continuing Operations of -$1.55 million for the 12-month period ending 2025-09-30, per its 10-K filed 2025-12-19.
Financial Statements › Expense Statement › Income Tax
us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations · last filed 2025-12-19
- OUTLOOK THERAPEUTICS, INC. foreign income tax expense (benefit), continuing operations for the quarter ending 2017-06-30 was $0.00, a 100.00% decline year-over-year.
- OUTLOOK THERAPEUTICS, INC. foreign income tax expense (benefit), continuing operations for the quarter ending 2017-03-31 was $0.00, a 100.00% decline year-over-year.
- OUTLOOK THERAPEUTICS, INC. foreign income tax expense (benefit), continuing operations for the quarter ending 2016-12-31 was $4.00K, a 92.31% decline year-over-year.
- OUTLOOK THERAPEUTICS, INC. foreign income tax expense (benefit), continuing operations for the quarter ending 2016-06-30 was $500.00, a 99.58% decline year-over-year.
- OUTLOOK THERAPEUTICS, INC. foreign income tax expense (benefit), continuing operations for fiscal 2025 was -$1.55M.
| Period end | Foreign Income Tax Expense (Benefit), Continuing Operations 3 month | Foreign Income Tax Expense (Benefit), Continuing Operations 6 month | Foreign Income Tax Expense (Benefit), Continuing Operations 9 month | Foreign Income Tax Expense (Benefit), Continuing Operations 12 month |
|---|---|---|---|---|
| 2025-09-30 | -$1.55M 10-K · filed 2025-12-19 | |||
| 2017-06-30 | $0.00 10-Q · filed 2017-08-14 | $0.00 derived: sum of 2 quarters · filed 2017-08-14 | $4.00K 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-15 | $4.00K 10-Q · filed 2017-05-15 | ||
| 2016-12-31 | $4.00K 10-Q · filed 2017-02-14 | |||
| 2016-06-30 | $500.00 10-Q · filed 2017-08-14 | $51.00K derived: sum of 2 quarters · filed 2017-08-14 | $103.00K 10-Q · filed 2017-08-14 | |
| 2016-03-31 | $50.50K 10-Q · filed 2017-05-15 | $102.50K 10-Q · filed 2017-05-15 | ||
| 2015-12-31 | $52.00K 10-Q · filed 2017-02-14 | |||
| 2015-06-30 | $120.00K 10-Q · filed 2016-08-15 | -$606.22K derived: sum of 2 quarters · filed 2016-08-15 | -$199.85K 10-Q · filed 2016-08-15 | |
| 2015-03-31 | -$726.22K 10-Q · filed 2016-06-27 | -$319.86K 10-Q · filed 2016-06-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |